Archive

• 2021-05-19 Regulatory

  First quarter - Introduction underway

  Read more

• 2021-05-17

  NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021

  Read more

• 2021-04-27

  Matthew E. Colpoys, Jr. nominated to the Board of Directors

  Read more

• 2021-03-17

  NeoDynamics presents preclinical results today

  Read more

• 2021-03-15

  Invitation - NeoDynamics presents preclinical results on March 17 at 13.00 CET

  Read more

• 2021-02-17 Regulatory

  NeoDynamics AB (publ) Full year report 2020

  Read more

• 2021-01-14

  NeoDynamics will be granted another European patent for its pulse biopsy tools

  Read more

• 2020-11-19 Regulatory

  NeoDynamics AB (publ) Third Quarter 2020

  Read more

• 2020-11-19 Regulatory

  NeoDynamics receives first UK order of pulse biopsy system NeoNavia

  Read more

• 2020-11-12

  NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis

  Read more

• 2020-11-02 Regulatory

  Jörgen Vrenning is retiring as CFO of NeoDynamics

  Read more

• 2020-10-21 Regulatory

  NeoDynamics carries out directed new share issue of approximately SEK 90 million and convenes extraordinary general meeting

  Read more

• 2020-10-21 Regulatory

  NeoDynamics announces intention to carry out a directed share issue of approximately 24 million shares and intention to call for Extraordinary General Meeting

  Read more

• 2020-09-25

  NeoDynamics is approaching launch of new pulse biopsy system NeoNavia - reputed international gynecologists and radiologists gained positive hands-on experience

  Read more

• 2020-08-21 Regulatory

  NeoDynamics AB (publ) Half year report 2020

  Read more

• 2020-07-06 Regulatory

  NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer

  Read more

• 2020-07-06 Regulatory

  NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer

  Read more

• 2020-05-26 Regulatory

  NeoDynamics AB (publ) First Quarter 2020

  Read more

• 2020-02-05 Regulatory

  NeoDynamics AB (publ) full-year report 2019

  Read more

• 2020-02-03

  A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.

  Read more

• 2020-01-28

  NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China

  Read more

• 2019-11-27

  NeoDynamics signs manufacturing agreement for NeoNavia

  Read more

• 2019-11-21 Regulatory

  NeoDynamics AB (publ) Third quarter Jul-Sep 2019

  Read more

• 2019-11-05

  For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer

  Read more

• 2019-10-29 Regulatory

  NeoDynamics receives regulatory approval for new breast cancer biopsy system

  Read more

• 2019-09-16

  NeoDynamics recruits a country manager for Germany, Switzerland and Austria

  Read more

• 2019-08-28 Regulatory

  NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting

  Read more

• 2019-08-28 Regulatory

  NeoDynamics Half-year report 2019

  Read more

• 2019-08-15

  New date for NeoDynamics semi-annual report 2019

  Read more

• 2019-05-22 Regulatory

  NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer

  Read more

• 2019-05-21 Regulatory

  NeoDynamics AB (publ) - Quarterly report January-March 2019

  Read more

• 2019-04-26 Regulatory

  NeoDynamics AB (publ) receives advance notice from U.S. Patent Office for a granted biopsy instrument patent

  Read more

• 2019-04-10

  New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm

  Read more

• 2019-02-21 Regulatory

  Year-end report 2018 - NeoDynamics

  Read more

• 2019-02-18

  New Swedish technology for breast cancer diagnosis tested by leading experts in Germany

  Read more

• 2018-12-07

  NeoNavia commercial version fully integrated according to plan

  Read more

• 2018-12-07

  First day of trading in NeoDynamics’ shares and warrants on Spotlight Stock Market

  Read more

• 2018-11-19 Regulatory

  NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market fully subscribed

  Read more

• 2018-11-12

  NeoDynamics participates on Stora Aktiedagen and in a Live Session with Småbolagsjakten today

  Read more

• 2018-11-06

  NeoDynamics participates in investor meetings during the IPO

  Read more

• 2018-11-06

  NeoDynamics introduces NeoNavia®, a micropulse biopsy system, to a wider audience in the UK

  Read more

• 2018-11-01

  New technology from NeoDynamics approved for study in Germany

  Read more

• 2018-10-31 Regulatory

  The subscription period in NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market begins today

  Read more

• 2018-10-30 Regulatory

  NeoDynamics AB (publ) announces approval on passportation of prospectus

  Read more

• 2018-10-29 Regulatory

  NeoDynamics AB (publ) publishes prospectus and enters agreement on additional subscription commitment

  Read more

• 2018-10-25 Regulatory

  NeoDynamics AB (publ) approved for listing on Spotlight Stock Market

  Read more